MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

TrovaGene Company Profile (NASDAQ:TROV)

Consensus Ratings for TrovaGene (NASDAQ:TROV) (?)
Ratings Breakdown: 6 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $7.20 (36.11% upside)

Analysts' Ratings History for TrovaGene (NASDAQ:TROV)
Show:
DateFirmActionRatingPrice TargetActions
5/12/2016Piper JaffrayReiterated RatingHold$8.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/11/2016Cantor FitzgeraldReiterated RatingHold$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016ArgusDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016Avondale PartnersReiterated RatingMarket Perform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/12/2016Maxim GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/25/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha